ABSTRACT. We investigated the influence of the c.1517G>C genetic variant in the X-ray repair complementing group 1 gene (XRCC1) on pancreatic cancer (PC) susceptibility in Chinese patients. A total of 390 PC patients and 392 controls were enrolled in this case-control study. The genotypes of c.1517G>C genetic variants were determined using polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Our findings suggested that the allele and genotype frequencies in PC patients were significantly different from those in cancer-free controls. The CC genotype was associated with an increased risk of PC compared to the wild-type GG genotype (odds ratio = 2.43, 95% confidence interval 1.43-4.13, c 2 = 11.19, P = 0.001). The C allele may contribute to the development of PC (C vs G, odds ratio = 1.32, 95% confidence interval 1.06-1.64, c 2 = 6.25, P = 0.012). Results from this study indicate that the c.1517G>C genetic variant of the XRCC1 gene is significantly associated with PC 
INTRODUCTION
Pancreatic cancer (PC) is one of the leading causes of cancer death worldwide. While the incidence of PC is increasing, the 5-year survival rate remains below 5% (Jemal et al., 2007; Tanaka et al., 2011; Nakao et al., 2012) . Possible risk factors for PC include advanced age, alcohol consumption, tobacco smoking, overweight, high body mass index, diabetes mellitus, and a family history of PC (Lowenfels and Maisonneuve, 2003; Li et al., 2006; Lowenfels and Maisonneuve, 2006; Larsson et al., 2007; Luo et al., 2007; Nakao et al., 2012) . Previous reports have identified a positive association between genetic variants and PC risk (Lin et al., 2001; Duell et al., 2002; Li et al., 2006 Li et al., , 2007 Nakao et al., 2012) . However, the exact mechanism of PC remains poorly understood. Several studies have reported that the human X-ray repair complementing group 1 gene (XRCC1) is an important candidate gene that influences PC risk (Duell et al., 2002; Jiao et al., 2006; Li et al., 2006 Li et al., , 2007 Wang et al., 2006; McWilliams et al., 2008; Shen et al., 2011; Nakao et al., 2012; Jiang et al., 2013; Yan et al., 2013; Chen et al., 2014) ; the potential associations between XRCC1 genetic variants and PC risk have been analyzed (Duell et al., 2002; Li et al., 2006 Li et al., , 2007 McWilliams et al., 2008; Nakao et al., 2012) . Some of these genetic variants, such as Arg194Trp, Arg280His, and Arg399Gln, were significantly associated with PC (Duell et al., 2002; Li et al., 2006 Li et al., , 2007 Nakao et al., 2012) . However, there have been no similar studies examining the association between the c.1517G>C genetic variant in the XRCC1 gene and PC risk. Therefore, we investigated this genetic variant to determine its influence on PC susceptibility.
MATERIAL AND METHODS

Study subjects
A total of 390 patients with diagnosed and histologically confirmed primary PC and 392 cancer-free controls were recruited for participation in the study from the Chinese PLA General Hospital between January 2008 and January 2013. All subjects were genetically unrelated Chinese individuals of Han ethnicity and lived in Beijing, China. Controls were frequency-matched to PC patients for age and gender. Subjects with a previous medical history of cancer or other medical diseases were excluded. Clinical characteristics for the populations studied are summarized in Table 1 , including age, gender, smoking status, alcohol consumption, diabetes mellitus, body mass index (BMI), and family history of PC. The study was approved by the ethical review committee at the Chinese PLA General Hospital. All study participants signed written informed consent. Mini kit (QIAGEN; Hilden, Germany) according to manufacturer instructions. Primers for polymerase chain reaction (PCR) were designed using the Primer Premier 5.0 software. Table  2 shows the primer sequences, annealing temperature, amplification fragment size, and region. The PCR reaction was carried out in a 20 mL mixture, containing 50 ng template DNA, 1X buffer (100 mM Tris-HCl, pH 8.3, 500 mM KCl), 0.25 mM primers, 2.0 mM MgCl 2 , 0.25 mM dNTPs, and 0.5 U Taq DNA polymerase (Promega; Madison, WI, USA). PCR amplification was achieved using 1 cycle at 94°C for 5 min, followed by 32 cycles at 94°C for 30 s, 58.4°C for 30 s, and 72°C for 30 s, and a final extension at 72°C for 5 min. The c.1517G>C genetic variant genotyping was determined using the PCR-restriction fragment length polymorphism (PCR-RFLP) method. PCR amplified products were digested with 5 U HaeIII restriction enzyme (MBI Fermentas; St. Leon-Rot, Germany) at 37°C for 10 h and electrophoresed on an agarose gel, and then visualized under ultraviolet light. To confirm the PCR-RFLP genotyping results, approximately 15% of the subjects were randomly selected for DNA sequencing (ABI3730xl DNA Analyzer; Applied Biosystems; Foster City, CA).
Statistical analysis
The chi-squared (c 2 ) test was used to assess Hardy-Weinberg equilibrium (HWE) in genotype frequencies and the differences in clinical characteristics of the studied populations. Unconditional logistic regression analysis was utilized to estimate the odds ratios (ORs) with their 95% confidence intervals (CIs) to determine the influence of having the c.1517G>C genetic variant on PC susceptibility. A P value < 0.05 was considered to be statistically significant. All statistical analyses were analyzed using SPSS 15.0 (SPSS Inc.; Chicago, IL, USA).
RESULTS
Subjects characteristics
A total of 782 subjects were enrolled in this case-control study, including 390 PC cases and 392 cancer-free controls. Table 1 shows the subject characteristics. Our data suggest that the PC patients were comparable to the cancer-free controls in terms of the distribution of gender, age, alcohol consumption, smoking status, diabetes mellitus, BMI, and family history of PC (all P > 0.05, Table 1 ). The distributions of genotype in PC patients and cancer-free controls did not significantly deviate from HWE (all P values > 0.05, Table 3 ).
Identification of XRCC1 genetic variant
Through PCR-RFLP and DNA sequencing methods, we identified the c.1517G>C genetic variant in the XRCC1 gene. The results of sequence analyses suggested that this genetic variant represents a non-synonymous mutation caused by G to C mutations in exon 14 of the XRCC1 gene. This change results in a glycine (Gly) to alanine (Ala) amino acid replacement (p.Gly506Ala, reference sequences GenBank IDs: NC_000019.9, NM_006297.2, and NP_006288.2). Amplified PCR products were digested with the HaeIII restriction enzyme and 3 genotypes were detected, GG (231 base pairs, bp), GC (231, 163, and 68 bp), and CC (163 and 68 bp) ( Table 2 ). Genotype and allele frequencies of PC patients and cancer-free controls are shown in Table 3 . The G-allele and GG-genotype were predominant in the studied subjects (Table 3 ). The allele frequencies in PC patients (G, 67.44%; C, 32.56%) were significantly different from those of cancer-free controls (G, 73.21%; C, 26.79%; c 2 = 6.26, P = 0.012). The genotype frequencies between the PC patients and cancer-free controls were significantly different (c 2 = 11.87, P = 0.003, Influence of the XRCC1 genetic variant on PC susceptibility Table 4 shows the influence of the c.1517G>C genetic variant in the XRCC1 gene on PC susceptibility. A significantly increased risk of PC was observed in the homozygote comparison (CC vs GG: OR = 2.43, 95%CI = 1.43-4.13, c 2 = 11.19, P = 0.001), recessive model (CC vs GC/GG: OR = 2.41, 95%CI = 1.44-4.04, c 2 = 11.85, P = 0.001), and allele contrast (C vs G: OR = 1.32, 95%CI = 1.06-1.64, c 2 = 6.25, P = 0.012). We detected no statistical association between this genetic variant and PC risk in the heterozygote comparison (GC vs GG: OR = 1.02, 95%CI = 0.76-1.37, χ 2 = 0.01, P = 1.367) and the dominant model (CC/GC vs GG: OR = 1.19, 95%CI = 0.90-1.58, c 2 = 1.48, P = 0.224). 
DISCUSSION
Various studies have shown that PC is a common solid cancer caused by complex interactions between genetic and environmental factors (Lin et al., 2001; Duell et al., 2002; Li et al., 2006 Li et al., , 2007 Rizzato et al., 2011; Nakao et al., 2012; Tong et al., 2012; Zhang et al., 2012) . It is well known that genetic factors play key roles in PC pathogenesis (Lin et al., 2001; Lowenfels and Maisonneuve, 2003; Duell et al., 2008; Landi, 2009; Chu et al., 2010; Nitsche et al., 2011) . It has also been suggested that the XRCC1 gene is one of the most important candidate genes influencing the susceptibility to PC (Duell et al., 2002; Li et al., 2006 Li et al., , 2007 McWilliams et al., 2008; Nakao et al., 2012) , and its genetic polymorphisms are involved in modulating PC risk (Duell et al., 2002; Hung et al., 2005; Li et al., 2006; Mandal et al., 2010) . Nakao et al. observed that XRCC1 Arg399Gln was significantly associated with PC risk in a Japanese population (Nakao et al., 2012) . Li et al. (2006) reported that XRCC1 Arg194Trp affects the clinical prognosis of patients with PC. McWilliams et al. reported no significant differences in PC risk for the Arg194Trp, Arg280His, and Arg399Gln genetic variants in the XRCC1 gene (McWilliams et al., 2008) . However, these observations are conflicting, limiting the understanding of PC risk. In this case-control study, we first evaluated the influence of c.1517G>C genetic variant in the XRCC1 gene on PC risk in a Chinese Han population through association analysis. We found that the distributions of genotype and allele frequencies in PC patients were significant different from those of cancer-free controls (P < 0.05, Table 3 ). The CC genotype was significantly associated with an increased risk of PC compared with the GG genotype and GC/GG carriers (P < 0.01, Table 4 ). The C allele and CC genotype of c.1517G>C genetic variant may contribute to an increased risk of PC. Our data indicate that c.1517G>C genetic variant in the XRCC1 gene is significantly associated with PC risk in the
